These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11953643)

  • 1. Pharmacologic defibrillation.
    Wann SR; Weil MH; Sun S; Tang W; Pellis T
    Crit Care Med; 2002 Apr; 30(4 Suppl):S154-6. PubMed ID: 11953643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cariporide for pharmacologic defibrillation after prolonged cardiac arrest.
    Wann SR; Weil MH; Sun S; Tang W; Yu T
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):161-9. PubMed ID: 12232565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
    Gazmuri RJ; Ayoub IM; Hoffner E; Kolarova JD
    Circulation; 2001 Jul; 104(2):234-9. PubMed ID: 11447092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
    Radhakrishnan J; Kolarova JD; Ayoub IM; Gazmuri RJ
    Transl Res; 2011 Feb; 157(2):71-80. PubMed ID: 21256459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
    Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M
    Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation.
    Kolarova J; Ayoub IM; Yi Z; Gazmuri RJ
    Crit Care Med; 2003 Jul; 31(7):2022-8. PubMed ID: 12847399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
    Ayoub IM; Kolarova J; Yi Z; Trevedi A; Deshmukh H; Lubell DL; Franz MR; Maldonado FA; Gazmuri RJ
    Circulation; 2003 Apr; 107(13):1804-9. PubMed ID: 12665493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation.
    Ayoub IM; Kolarova J; Kantola RL; Sanders R; Gazmuri RJ
    Crit Care Med; 2005 Nov; 33(11):2599-605. PubMed ID: 16276186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation.
    Kolarova J; Yi Z; Ayoub IM; Gazmuri RJ
    Chest; 2005 Apr; 127(4):1327-34. PubMed ID: 15821211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity.
    Ayoub IM; Kolarova J; Gazmuri RJ
    Resuscitation; 2010 Jan; 81(1):106-10. PubMed ID: 19853351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse postresuscitation myocardial effects elicited by buffer-induced alkalemia ameliorated by NHE-1 inhibition in a rat model of ventricular fibrillation.
    Lamoureux L; Radhakrishnan J; Mason TG; Kraut JA; Gazmuri RJ
    J Appl Physiol (1985); 2016 Nov; 121(5):1160-1168. PubMed ID: 27633736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism by which activation of delta-opioid receptor reduces the severity of postresuscitation myocardial dysfunction.
    Fang X; Tang W; Sun S; Huang L; Huang Z; Weil MH
    Crit Care Med; 2006 Oct; 34(10):2607-12. PubMed ID: 16775573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival.
    Cammarata G; Weil MH; Sun S; Tang W; Wang J; Huang L
    Crit Care Med; 2004 Sep; 32(9 Suppl):S440-3. PubMed ID: 15508675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epinephrine increases the severity of postresuscitation myocardial dysfunction.
    Tang W; Weil MH; Sun S; Noc M; Yang L; Gazmuri RJ
    Circulation; 1995 Nov; 92(10):3089-93. PubMed ID: 7586280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of interrupting precordial compression during cardiopulmonary resuscitation.
    Sato Y; Weil MH; Sun S; Tang W; Xie J; Noc M; Bisera J
    Crit Care Med; 1997 May; 25(5):733-6. PubMed ID: 9187589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buffer agents on postresuscitation myocardial dysfunction.
    Sun S; Weil MH; Tang W; Fukui M
    Crit Care Med; 1996 Dec; 24(12):2035-41. PubMed ID: 8968273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is all ventricular fibrillation the same? A comparison of ischemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model.
    Niemann JT; Rosborough JP; Youngquist S; Thomas J; Lewis RJ
    Crit Care Med; 2007 May; 35(5):1356-61. PubMed ID: 17414084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cariporide in cardiac resuscitation--Does it really make a difference?
    Laudi S; Vu Tran Z; Steudel W
    Crit Care Med; 2005 Nov; 33(11):2707-8. PubMed ID: 16276214
    [No Abstract]   [Full Text] [Related]  

  • 20. A lazaroid mitigates postresuscitation myocardial dysfunction.
    Wang J; Weil MH; Kamohara T; Tang W; Sun S; Klouche K; Bisera J
    Crit Care Med; 2004 Feb; 32(2):553-8. PubMed ID: 14758178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.